◀ Back to IL4
CCL24 — IL4
Text-mined interactions from Literome
Watanabe et al., J Immunol 2002
:
Eotaxin-2 generation is differentially
regulated by lipopolysaccharide and
IL-4 in monocytes and macrophages ... Indeed,
IL-4 suppressed the generation of
eotaxin-2 by LPS stimulated monocytes ... Moreover,
IL-4 , but not LPS,
up-regulated the production of
eotaxin-2 by macrophages
Meyer-Hoffert et al., Int Arch Allergy Immunol 2003
:
IL-4 and to a lesser extent IL-13 and IFN-gamma
stimulated the production of MCP-3 and -4, eotaxin and
eotaxin-2 immunoreactivities
Lezcano-Meza et al., Allergy 2003
(Nasal Polyps) :
IL-4 induced
eotaxin-2/CCL24 in a dose dependent manner with concentrations as low as 0.1 ng/ml being able to induce eotaxin-2/CCL24
Kobayashi et al., Ann Allergy Asthma Immunol 2004
:
Eotaxin-1 and eotaxin-3, but not
eotaxin-2 , mRNA expressions were
induced by stimulation with interleukin (IL) 13 or
IL-4
Kagami et al., Clin Exp Immunol 2005
(Dermatitis, Atopic) :
The production of
CCL24 in HaCaT cells was slightly
enhanced by
IL-4 and that of CCL26 was strongly enhanced by IL-4 and IL-13
van Wetering et al., Mol Immunol 2007
:
Epithelial differentiation is a determinant in the production of
eotaxin-2 and -3 by bronchial epithelial cells in
response to
IL-4 and IL-13 ... TNFalpha reduced
IL-4 induced
eotaxin-2 release in submerged cultures but not in ALI-cultures ; no effects on eotaxin-3 synthesis were observed
Errahali et al., J Interferon Cytokine Res 2009
(Asthma) :
Results demonstrate that CCL26-siRNA treatments decreased
interleukin-4 induced CCL26 and
CCL24 expression by > 70 %
Wu et al., Clin Exp Allergy 2009
(Asthma...) :
Primary alveolar macrophages ( pAMs ) from naïve BALB/c mice were cultured to determine whether Mp-induced PGE ( 2 ) or exogenous PGE ( 2 ) down-regulates
IL-4/IL-13 induced
eotaxin-2 ... In pAMs,
IL-4/IL-13 significantly
increased eotaxin-2 , which was reduced by Mp infection accompanied by dose dependent PGE ( 2 ) induction ... Exogenous PGE ( 2 ) inhibited
IL-4/IL-13 induced
eotaxin-2 in a dose dependent manner